Healthcare

Healthcare·Innovation·Market·News·Sport·Technology

How Anteris Technologies is Shaping the Future of Heart Valve Innovation with a Year of Milestones

Anteris Technologies strengthens its position in the US market by listing on Nasdaq and raising $88.8 million. The company plans to submit an Investigational Device Exemption to the FDA for its DurAVR® Transcatheter Heart Valve by Q1 2025. Anteris engages in strategic

13. March 2025

Global News·Healthcare·Market·News·Pharmaceuticals

Global Powerhouses Join Forces: A New Era for Rare Blood Disease Treatment

Ionis Pharmaceuticals and Ono Pharmaceutical have partnered to target polycythemia vera (PV), a rare blood disorder. Sapablursen, an RNA-targeted therapy, is central to their endeavor, having completed a Phase 2 trial with FDA Fast Track and orphan drug designations. The agreement includes

12. March 2025

Biotech·Healthcare·Investing·Market·News

Biotech’s Bold Move: Inside Agenus’ Quest to Revolutionize Cancer Treatment

Agenus Inc. is advancing BOT/BAL therapy, aiming to revolutionize cancer treatment. BOT/BAL shows promise in combating microsatellite stable (MSS) colorectal cancer, a difficult-to-treat form. Strategic focus on BOT/BAL has led Agenus to reduce operational expenditures and monetize non-core assets. High-profile partnerships and

11. March 2025

Business·Finance·Healthcare·Investment·Market·News

The Hidden Gem Among Healthcare Giants: Why Merck & Co. is a Hedge Fund Favorite

Merck & Co., Inc. (NYSE:MRK) is highlighted as a stable and growth-oriented investment within the volatile stock market, driven by its pioneering efforts in healthcare. KEYTRUDA, Merck’s leading oncology product, saw a 21% increase in sales in the last quarter of 2024,

10. March 2025

Finance·Growth Stocks·Healthcare·Market·News·S&P 500·Stocks

Is UnitedHealth Group Positioned for a Resurgence Amidst Market Shifts?

UnitedHealth Group (NYSE:UNH) experienced mixed results in 2024, facing operational hurdles yet showing potential for resurgence. Despite market volatility, UNH’s strength is underpinned by significant market capitalization of $451.392 billion and over $400 billion in revenue. UnitedHealth reported adjusted earnings per share

10. March 2025

Business·Business Success·Digital Transformation·Healthcare·Market·News·Travel

Unlocking the Surge: How Doximity Became a Healthcare Powerhouse

Doximity, Inc., known as the “LinkedIn for medical professionals,” has become a vital platform for doctors in the U.S., with 80% reportedly using its services. The company’s share price soared by 165.11% in 2024, reaching $75 per share, driven by strategic pharmaceutical

21. February 2025

Business Analysis·Healthcare·Market·News·Risk Management

Beneath the Numbers: A Cautionary Tale for Charles River Laboratories

Charles River Laboratories experienced a significant 98% drop in net income, with profit margins reduced to 0.3%. Earnings per share have fallen sharply from $9.27 to $0.20, raising concerns among investors. The company reported a slight dip in revenue to $4.05 billion,

21. February 2025